Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Dihydroxyphenylalanine and Ascorbate

Research Papers that Mention the Interaction

However, when cultures were pretreated with both l‐DOPA and ascorbate , which prevents the rise in GSH level, protection was lost, in accord with the failure to up‐regulate GSH.
Journal of neurochemistry  •  1996  |  View Paper
In vitro L-DOPA dihydroxyphenylalanine ) is toxic to DA cells and this is prevented by ascorbate '', Ascorbate therapy in early Parkinson's disease delays the need to give L-DOPA by 2 years".
Journal of the Royal Society of Medicine  •  1996  |  View Paper
The data indicate that: (a) the uptake systems for ascorbate and tocopherols in these cells are inhibited by L‐dopa and/or (b) L‐dopa treatment causes an increase in the rate of utilization of the two nutrients.
Thus L‐dopa modulates the cellular dynamics of ascorbate and tocopherol altering cellular antioxidant protection.
Annals of the New York Academy of Sciences  •  2006  |  View Paper
3,4-Dihydroxyphenylalanine at high concentration is an inhibitor of tyrosine hydroxylation, while tyrosine acts as a substrate inhibitor at concentrations above 8 … can be partially reversed by increasing the concentration of 3,4-dihydroxyphenylalanine from the catalytic level to 8 x 10-4 m. Ascorbate … 3,4-dihydroxyphenylalanine.
The Journal of biological chemistry  •  1966  |  View Paper